VIATRIS INC. Tax Withholding Paid on Stock Awards
VIATRIS INC. (VTRS) reported Tax Withholding Paid on Stock Awards of $56.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-06
- VIATRIS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $300.00K, a 50.00% increase year-over-year.
- VIATRIS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $56.50M, a 92.83% increase year-over-year.
- VIATRIS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was -$100.00K.
- VIATRIS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $800.00K, a 96.23% decline year-over-year.
- VIATRIS INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $30.20M, a 43.34% decline from fiscal 2024.
- VIATRIS INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $53.30M, a 39.53% increase from fiscal 2023.
- VIATRIS INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $38.20M, a 120.81% increase from fiscal 2022.
- VIATRIS INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $17.30M, a 0.57% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $56.80M 10-Q · filed 2026-08-06 | $56.70M derived: sum of 3 quarters · filed 2026-08-06 | $57.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $56.50M 10-Q · filed 2026-05-07 | $56.40M derived: sum of 2 quarters · filed 2026-05-07 | $57.20M derived: sum of 3 quarters · filed 2026-05-07 | $57.40M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $700.00K derived: sum of 2 quarters · filed 2026-02-26 | $900.00K derived: sum of 3 quarters · filed 2026-08-06 | $30.20M 10-K · filed 2026-02-26 |
| 2025-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.00M derived: sum of 2 quarters · filed 2026-08-06 | $30.30M 10-Q · filed 2025-11-06 | $30.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $29.50M 10-Q · filed 2026-08-06 | $29.50M derived: sum of 3 quarters · filed 2026-08-06 | $50.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $29.30M 10-Q · filed 2026-05-07 | $29.30M derived: sum of 2 quarters · filed 2026-05-07 | $50.50M derived: sum of 3 quarters · filed 2026-05-07 | $53.90M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $21.20M derived: sum of 2 quarters · filed 2026-02-26 | $24.60M derived: sum of 3 quarters · filed 2026-02-26 | $53.30M 10-K · filed 2026-02-26 |
| 2024-09-30 | $21.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $24.60M derived: sum of 2 quarters · filed 2025-11-06 | $53.30M 10-Q · filed 2025-11-06 | $58.90M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $32.10M 10-Q · filed 2025-08-07 | $37.70M derived: sum of 3 quarters · filed 2026-02-26 | $40.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $28.70M 10-Q · filed 2025-05-08 | $34.30M derived: sum of 2 quarters · filed 2026-02-26 | $36.90M derived: sum of 3 quarters · filed 2026-02-26 | $36.90M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.20M derived: sum of 2 quarters · filed 2026-02-26 | $8.20M derived: sum of 3 quarters · filed 2026-02-26 | $38.20M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.60M derived: sum of 2 quarters · filed 2024-11-07 | $32.60M 10-Q · filed 2024-11-07 | $36.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $30.00M 10-Q · filed 2024-08-08 | $33.90M derived: sum of 3 quarters · filed 2025-02-27 | $34.10M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $30.00M 10-Q · filed 2024-05-09 | $33.90M derived: sum of 2 quarters · filed 2025-02-27 | $34.10M derived: sum of 3 quarters · filed 2025-02-27 | $37.40M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.10M derived: sum of 2 quarters · filed 2025-02-27 | $7.40M derived: sum of 3 quarters · filed 2025-02-27 | $17.30M 10-K · filed 2025-02-27 |
| 2022-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $3.50M derived: sum of 2 quarters · filed 2023-11-08 | $13.40M 10-Q · filed 2023-11-08 | $13.70M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $13.20M 10-Q · filed 2023-08-07 | $13.50M derived: sum of 3 quarters · filed 2024-02-28 | $17.10M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $9.90M 10-Q · filed 2023-05-08 | $10.20M derived: sum of 2 quarters · filed 2024-02-28 | $13.80M derived: sum of 3 quarters · filed 2024-02-28 | $19.50M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.90M derived: sum of 2 quarters · filed 2024-02-28 | $9.60M derived: sum of 3 quarters · filed 2024-02-28 | $17.40M 10-K · filed 2024-02-28 |
| 2021-09-30 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $9.30M derived: sum of 2 quarters · filed 2022-11-07 | $17.10M 10-Q · filed 2022-11-07 | $17.90M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $5.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $13.50M 10-Q · filed 2022-08-08 | $14.30M derived: sum of 3 quarters · filed 2023-02-27 | $14.30M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $7.80M 10-Q · filed 2022-05-09 | $8.60M derived: sum of 2 quarters · filed 2023-02-27 | $8.60M derived: sum of 3 quarters · filed 2023-02-27 | $10.70M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $800.00K derived: sum of 2 quarters · filed 2023-02-27 | $2.90M derived: sum of 3 quarters · filed 2023-02-27 | $7.90M 10-K · filed 2023-02-27 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $2.10M derived: sum of 2 quarters · filed 2021-11-08 | $7.10M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $7.10M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $5.00M 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $8.40M 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $10.10M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |